Cargando…
A low-dose therapy of fibrinogen supplement during perioperative period of total knee arthroplasty in an asymptomatic man with congenital dysfibrinogenemia: A case report
Congenital dysfibrinogenemia (CD) is a rare coagulation system disease that is often treated without unified management. Individualized treatment thereof presents clinicians with great challenges. PATIENT CONCERNS: A patient who was about to undergo total knee arthroplasty was found to have CD. DIAG...
Autores principales: | Meng, Decheng, Zhang, Runzi, Ji, Chenni, Gao, Shijun, Wang, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678536/ https://www.ncbi.nlm.nih.gov/pubmed/36401403 http://dx.doi.org/10.1097/MD.0000000000031644 |
Ejemplares similares
-
Fibrinogen Yecheon: Congenital Dysfibrinogenemia with Gamma Methionine-310 to Threonine Substitution
por: Park, Eunkyung, et al.
Publicado: (2009) -
The incidence and risk factors of contralateral knee arthroplasty after primary unilateral unicompartmental knee arthroplasty
por: Huang, Xiaodan, et al.
Publicado: (2021) -
Continuous glycemia monitoring in perioperative period in patients undergoing total knee or hip arthroplasty: A protocol for a prospective observational study
por: Adamska, Olga, et al.
Publicado: (2022) -
Application of dexamethasone combined with tranexamic acid in perioperative period of total hip arthroplasty
por: Li, Fulin, et al.
Publicado: (2022) -
Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia
por: Martini, Francesca, et al.
Publicado: (2019)